QIAGEN Clinical Insight bioinformatics platform

Wednesday, 27 May, 2015 | Supplied by: QIAGEN Pty Ltd

QIAGEN has announced the launch of the QIAGEN Clinical Insight (QCI) bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS). The first two supported applications for the bioinformatics platform are in oncology, for somatic and hereditary cancer testing.

The platform is an evidence-based decision support solution that evaluates genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels and clinical trials. Using a powerful software platform, the secure QCI web application and QIAGEN’s private data centre, clinicians can rapidly classify variants, identify treatment options and perform geographical clinical trial matching.

The product supports both germline and somatic test indication, which is important to labs offering diverse test indications. It provides full platform- and assay-agnostic interpretation and reporting workflow support, which enables clinical testing labs to reduce time and cost associated with NGS-based testing. It also provides access to the Allele Frequency Community, a large repository of ancestral and ethnic diversity data.

Online: www.qiagen.com
Phone: 03 9840 9800
Related Products

3M Petrifilm Plates and Plate Reader

The 3M Petrifilm Plates and Plate Reader are designed to distil the complexity, variability and...

3M Molecular Detection System

The 3M Molecular Detection System is designed to help save time and labour with its ready-to-use...

3M Clean-Trace ATP-based Hygiene Monitoring and Management System

The 3M Clean-Trace ATP-based Hygiene Monitoring and Management System features a Luminometer LM1...

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd